शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
CARERATINGNSECARE Ratings Limited· Capital MarketsHighPositive
Announced Wed, 12 Nov, 2025 · 18:51 IST

CARE Ratings declares Rs 8 interim dividend, Q2 profit up 22% YoY

CARERATING · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.2%Reaction day
₹1525.90
prior close
₹1631.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+5.3% vs market
Capital Markets peers, median of 61sector · industry level-0.2%+5.4% vs sector

On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.4 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.3
15m
+0.3
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.2-0.1+5.3-0.2+5.4
Next day
+5.6-0.2+5.8-1.0+6.6
2d
+0.6+0.4+0.2-0.9+1.6
3d
+0.3-0.4+0.7-0.9+1.2
4d
+0.2-0.6+0.8-1.7+1.9
5d
-0.9-0.9-0.1-0.9-0.0
1w
-1.8-3.0+1.2-2.9+1.1
15d
+0.3-3.9+4.2-3.4+3.8
1m
-0.1-4.8+4.8-4.1+4.1
2m
+5.6-7.8+13.3-7.5+13.1
3m
+6.2-7.2+13.4-12.6+18.7
UpDownMarket · Nifty Microcap 250Sector · Capital Markets peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 FY26 results. Consolidated net profit rose 22% YoY to Rs 57.2 crore; revenue up 16% at Rs 136.4 crore. Interim dividend of Rs 8 per share declared on face value Rs 10 with record date November 19, 2025. Also appointed Dr. Bimal Patel as Independent Director for 3 years, granted 5,000 ESOPs at Rs 1,567, and approved selling 9.9% stake each in subsidiary CareEdge Global IFSC to SBI and NSEIFSC for Rs 5.94 crore.

Likely market impact

Strong profit growth and dividend payout signal healthy business. Subsidiary stake sale is small and non-core. Q2 beat may lift sentiment.